Pescia Carlo

Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment / B. Taurelli Salimbeni, F. Giudici, C. Pescia, P.P.M. BERTON GIACHETTI, R. Scafetta, P. Zagami, A. Marra, D. Trapani, A. Esposito, S. Scagnoli, B. Cerbelli, A. Botticelli, E. Munzone, N. Fusco, C. Criscitiello, G. Curigliano. - In: NPJ BREAST CANCER. - ISSN 2374-4677. - 11:1(2025), pp. 41.1-41.12. [10.1038/S41523-025-00760-9]

The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy / K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1422-0067. - 25:11(2024), pp. 5717.1-5717.13. [10.3390/ijms25115717]

Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer / M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco. - In: VIRCHOWS ARCHIV. - ISSN 0945-6317. - 484:1(2024), pp. 3-14. [10.1007/s00428-023-03656-w]

The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis / C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci. - In: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. - ISSN 0926-9959. - (2024), pp. 1-4. [Epub ahead of print] [10.1111/jdv.19845]

The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective / C. Pescia, G. Lopez, D. Cattaneo, C. Bucelli, U. Gianelli, A. Iurlo. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 136:(2024 Jan), pp. 107420.1-107420.10. [10.1016/j.leukres.2023.107420]